GSK3B and breast cancer: In the present study, we discovered that the cytoplasmic AQP1 and GSK3β competitively interacted with the 12 armadillo repeats of β-catenin, a reaction that could inhibit the ubiquitin-proteasome degradation pathway of β-catenin in AQP1 overexpressed breast cancer cells.